Diant Pharma Inc.

CIK 1949139 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Diant Pharma Inc..

Recent SEC filings

FiledFormAccession number
May 8, 2026C-AR0001949139-26-000004
May 8, 2025C-U0001665160-25-001035
Mar 12, 2025C/A0001665160-25-000411
Dec 26, 2024C-U0001665160-24-001889
Dec 11, 2024C0001665160-24-001794
Sep 30, 2022D0001949139-22-000001